Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Threshold Pharmaceuticals Inc (NASDAQ:THLD)

0.6592
Delayed Data
As of Feb 17
 -0.0208 / -3.06%
Today’s Change
0.21
Today|||52-Week Range
1.48
+49.48%
Year-to-Date
No recent news for Threshold Pharmaceuticals Inc.

Today’s Trading

Previous close0.68
Today’s open0.68
Day’s range0.64 - 0.70
Volume814,607
Average volume (3 months)871,297
Market cap$47.2M
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-164.81%
Earnings growth (next 5 years)--
Revenue growth (last year)+422.45%
P/E ratio1.1
Price/Sales0.46
Price/Book1.15

Competitors

 Today’s
change
Today’s
% change
IMMYImprimis Pharmaceuti...-0.25-8.96%
EBIOEleven Biotherapeuti...+0.04+1.96%
CHMAChiasma Inc+0.20+12.50%
ITEKInotek Pharmaceutica...+0.02+1.56%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$76.9M
Annual profit (last year)$43.8M
Net profit margin56.97%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Harold E. Selick
Vice President-
Clinical Operations
Kristen Quigley
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs